Gene name   H4IIE   H4H1   2D-hepatocyte sandwich   3D-liver microtissue
Day 4              Day 25 Day 4              Day 25
  Glucocorticoid pathway
PCK1 32.0 ± 0.8 21.4 ± 1.2 33.5 ± 1.3 34.3 ± 1.7 25.5 ± 0.4 27.5 ± 0.1
ORM1 30.1 ± 0.4 30.0 ± 0.2 20.5 ± 2.3 25.4 ± 0.3 19.6 ± 1.3 21.7 ± 1.0
G6PC 32.3 ± 1.9 21.5 ± 0.5 34.2 ± 0.6 34.1 ± 0.7 27.1 ± 0.6 27.4 ± 0.1
H6PD 29.5 ± 1.1 30.5 ± 0.5 34.1 ± 3.3 35.9 ± 0.3 30.5 ± 0.6 30.8 ± 0.5
H11B1 34.7 ± 0.1 27.3 ± 0.6 31.1 ± 0.4 33.7 ± 4.9 24.2 ± 0.9 23.4 ± 0.4
 Anti-oxidant cell defense pathway
ABCC3 27.0 ± 0.6 27.7 ± 0.3 28.8 ± 1.3 31.6 ± 1.9 27.8 ± 1.6 28.7 ± 1.2
NQO1 24.8 ± 0.4 22.9 ± 0.6 28.6 ± 0.2 30.7 ± 2.1 25.6 ± 2.5 27.0 ± 1.0
GSTA2 24.8 ± 1.7 28.8 ± 0.6 30.9 ± 1.6 33.0 ± 0.7 20.5 ± 0.9 21.0 ± 1.2
NFE2L2 21.3 ± 0.5 20.5 ± 0.9 28.3 ± 2.2 30.6 ± 2.0 25.1 ± 1.9 24.9 ± 0.1
  Other (redox pathway)
G6PD 23.9 ± 0.8 24.7 ± 0.2 28.4 ± 0.2 30.9 ± 1.9 28.4 ± 1.2 29.0 ± 1.7
  House-keeping
PPIA 24.1 ± 0.2 19.2 ± 0.1 22.8 ± 0.5 23.5 ± 0.8 22.3 ± 0.1 21.8 ± 0.7
Table 1: Overview of mRNA expression levels in rat liver in vitro models.